{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:45:02Z","timestamp":1793108702655,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Deanship of Scientific Research, King Saud University (KSU), Riyadh, Saudi Arabia"},{"name":"Ministry of Higher Education in Saudi Arabia and KSU"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.reprotox.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,3,31]],"date-time":"2015-03-31T01:34:41Z","timestamp":1427765681000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["First trimester exposure to topiramate and the risk of oral clefts in the offspring: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0611-9876","authenticated-orcid":false,"given":"Abdulaziz M.S.","family":"Alsaad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9852-6411","authenticated-orcid":false,"given":"Shahnaz Akthar","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.reprotox.2015.03.003_bib0170","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0b013e3181a6b2f8","volume":"73","author":"Harden","year":"2009","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.reprotox.2015.03.003_bib0175","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1528-1167.2009.02130.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"issue":"15","key":"10.1016\/j.reprotox.2015.03.003_bib0180","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1056\/NEJM200104123441504","article-title":"The teratogenicity of anticonvulsant drugs","volume":"344","author":"Holmes","year":"2001","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.reprotox.2015.03.003_bib0185","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/aje\/153.10.961","article-title":"Neural tube defects in relation to use of folic acid antagonists during pregnancy","volume":"153","author":"Hernandez-Diaz","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"11","key":"10.1016\/j.reprotox.2015.03.003_bib0190","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann Epidemiol"},{"issue":"4","key":"10.1016\/j.reprotox.2015.03.003_bib0195","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1526-4610.2010.01650.x","article-title":"Commentary: triptan use during pregnancy: a safe choice?","volume":"50","author":"Kurth","year":"2010","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.reprotox.2015.03.003_bib0200","first-page":"811","article-title":"Topiramate in the treatment of partial and generalized epilepsy","volume":"3","author":"Faught","year":"2007","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"4","key":"10.1016\/j.reprotox.2015.03.003_bib0205","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.ncl.2010.03.025","article-title":"Treatment options for parasomnias","volume":"28","author":"Attarian","year":"2010","journal-title":"Neurol Clin"},{"issue":"4","key":"10.1016\/j.reprotox.2015.03.003_bib0210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.5664\/jcsm.27883","article-title":"Best practice guide for the treatment of nightmare disorder in adults","volume":"6","author":"Aurora","year":"2010","journal-title":"J Clin Sleep Med"},{"issue":"6","key":"10.1016\/j.reprotox.2015.03.003_bib0215","first-page":"CD005653","article-title":"Pharmacological interventions for borderline personality disorder","author":"Stoffers","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.reprotox.2015.03.003_bib0220","doi-asserted-by":"crossref","first-page":"716","DOI":"10.4088\/JCP.09m05266gre","article-title":"Double-blind: placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder","volume":"72","author":"Berlin","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.reprotox.2015.03.003_bib0225","unstructured":"SDI, Vector One\u00ae: National (VONA) and Total Patient Tracker (TPT). January 2007\u2013December 2010. Data extracted 02.09.11."},{"issue":"11","key":"10.1016\/j.reprotox.2015.03.003_bib0230","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2165\/00023210-200216110-00004","article-title":"Teratogenic potential of the newer antiepileptic drugs: what is known and how should this influence prescribing?","volume":"16","author":"Palmieri","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.reprotox.2015.03.003_bib0235","series-title":"Full prescribing information for Topamax","author":"Topamax","year":"2014"},{"issue":"21","key":"10.1016\/j.reprotox.2015.03.003_bib0240","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.reprotox.2015.03.003_bib0245","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.reprotox.2015.03.003_bib0250","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.reprotox.2008.03.001","article-title":"The outcome of pregnancy following topiramate treatment: a study on 52 pregnancies","volume":"25","author":"Ornoy","year":"2008","journal-title":"Reprod Toxicol"},{"issue":"5","key":"10.1016\/j.reprotox.2015.03.003_bib0255","doi-asserted-by":"crossref","first-page":"405.e1","DOI":"10.1016\/j.ajog.2012.07.008","article-title":"Use of topiramate in pregnancy and risk of oral clefts","volume":"207","author":"Margulis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.reprotox.2015.03.003_bib0260","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pds.3612","article-title":"Topiramate use in pregnancy and the birth prevalence of oral clefts","volume":"23","author":"Mines","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.reprotox.2015.03.003_bib0265","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1526-4610.2012.02190.x","article-title":"Utilization of topiramate during pregnancy and risk of birth defects","volume":"52","author":"Green","year":"2012","journal-title":"Headache"},{"issue":"19","key":"10.1016\/j.reprotox.2015.03.003_bib0270","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2011.624","article-title":"Newer-generation antiepileptic drugs and the risk of major birth defects","volume":"305","author":"Molgaard-Nielsen","year":"2011","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.reprotox.2015.03.003_bib0275","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/ane.12115","article-title":"Associations between particular types of fetal malformation and antiepileptic drug exposure in utero","volume":"128","author":"Vajda","year":"2013","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.reprotox.2015.03.003_bib0280","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1479-828X.2007.00781.x","article-title":"The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies","volume":"47","author":"Vajda","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"9","key":"10.1016\/j.reprotox.2015.03.003_bib0285","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/ptj\/89.9.873","article-title":"Reprint \u2013 preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"89","author":"Moher","year":"2009","journal-title":"Phys Ther"},{"issue":"2","key":"10.1016\/j.reprotox.2015.03.003_bib0290","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/157488912800673128","article-title":"Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence","volume":"7","author":"Barron","year":"2012","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"3","key":"10.1016\/j.reprotox.2015.03.003_bib0295","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-2918(97)80140-3","article-title":"Pharmacoeconomic applications of meta-analysis for single groups using antifungal onychomycosis lacquers as an example","volume":"19","author":"Einarson","year":"1997","journal-title":"Clin Ther"},{"issue":"6","key":"10.1016\/j.reprotox.2015.03.003_bib0300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.reprotox.2015.03.003_bib0315","unstructured":"FDA. FDA Drug Safety Communication: risk of oral clefts in children born to mothers taking Topamax (topiramate) (http:\/\/www.fda.gov\/Drugs\/Drugsafety\/ucm245085.htm). Available from: http:\/\/www.fda.gov\/Drugs\/Drugsafety\/ucm245085.htm [accessed 20.10.14]."},{"issue":"2","key":"10.1016\/j.reprotox.2015.03.003_bib0320","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/tera.10069","article-title":"Classification of drugs for teratogenic risk: an anachronistic way of counseling","volume":"66","author":"Merlob","year":"2002","journal-title":"Teratology"},{"issue":"10","key":"10.1016\/j.reprotox.2015.03.003_bib0325","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1528-1157.2002.12502.x","article-title":"Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations","volume":"43","author":"Ohman","year":"2002","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.reprotox.2015.03.003_bib0330","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2165\/00002018-200427030-00004","article-title":"Malformation rates in children of women with untreated epilepsy: a meta-analysis","volume":"27","author":"Fried","year":"2004","journal-title":"Drug Saf"}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623815000374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623815000374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:38:31Z","timestamp":1760189911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623815000374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":31,"alternative-id":["S0890623815000374"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2015.03.003","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First trimester exposure to topiramate and the risk of oral clefts in the offspring: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}